India opens Drug Inspection Office in China
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
In November 2008, the U.S. Food and Drug Administration (FDA) has opened its first office in Beijing, China with the goal to strengthen the safety, quality, and effectiveness of food and medical products produced in China for export to the United States. Now, India wants to open its first drug inspection office on 01 March 2013.
The plan is that the office will host four drug inspectors who will be in charge of inspecting manufacturing sites and check if the comply with good manufacturing practices (GMP).
"We will post Indian drug inspectors in China to send a clear message that Chinese drug firms are under watch. We will gradually ask China to only allow drugs exports from manufacturing sites which have been inspected by Indian drug inspectors. We want to ensure safety, efficacy and quality of Chinese drugs," Dr Singh told the Times Of India news.
Related GMP News
23.09.2026FDA Inspection as GMP Evidence? Swissmedic Opens Up a New Option
23.09.2026New: Coordination of GMP Inspections for Centrally Authorised Products
16.09.2026How GMP Non-Compliance can stop a Marketing Authorisation Application
10.09.2026FDA Warning Letter: Inadequate Warehouse Controls and Lot Traceability
09.09.2026Specified Microorganisms and More - FDA Warning Letter